Hepatitis C virus (HCV) infection remains a major public health issue with high prevalence in
Taiwan. Recently, the advent of direct-acting antiviral (DAA) agents, with higher efficacy …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

Abstract Background Introduced in 2013–2014, the second-and third-wave directly acting
antivirals (DAAs) have strongly enhanced the efficacy and tolerability of anti-HCV treatment …

Dr. Aronsohn has no relevant financial affiliations to disclose (updated November 12, 2019).
Dr. Bhattacharya has no relevant financial affiliations to disclose (updated November 13 …

Die Medizin unterliegt einem fortwährenden Entwicklungsprozess, sodass alle Angaben,
insbesondere zu diagnostischen und therapeutischen Verfahren, immer nur dem …

Aims Pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO
Country Office in China on 31 December 2019. The outbreak was declared a Public Health …

Background: Approximately 3.5 million children and adolescents worldwide are chronically
infected with HCV. This study uses pharmacokinetic modeling to identify pediatric doses of …

Chronic hepatitis C virus (HCV) infection is common among patients with chronic kidney
disease (CKD) and those on hemodialysis due to nosocomial infections and past blood …

The availability of safe, efficacious, oral direct-acting antivirals (DAAs) have ushered in a
new era of hepatitis C treatment with potential to eliminate hepatitis C as a public health …

Methods These treatment guidelines were developed by first defining a set of objectives and
then conducting a systematic review of the literature aimed at responding to the questions …